Read + Share
Stahl M, Tallman MS, Goldberg AD. Measurable residual disease negativity in acute myeloid leukemia: the destination
may matter more than the journey. Leuk Lymphoma 2021 Sep 14:1-2. doi: 10.1080/10428194.2021.1929967.
PMID: 34519611
|
 |
|
Stahl M, Tallman MS, Goldberg AD. Measurable residual disease negativity in acute myeloid leukemia: the destination
may matter more than the journey. Leuk Lymphoma 2021 Sep 14:1-2. doi: 10.1080/10428194.2021.1929967.
PMID: 34519611
|
|
|
|